References
- WHO scientific brief. Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2, 2021. [updated 2021 February 8; cited 2021 July 30]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-mother-to-child-transmission-2021.1.
- Salem D, Katranji F, Bakdash T. COVID-19 infection in pregnant women: review of maternal and fetal outcomes. Int J Gynecol Obstet. 2021;152(3):291–298.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341.
- Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7(3):177–188.
- Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
- von Hippel PT. The heterogeneity statistic I(2) can be biased in small meta-analyses. BMC Med Res Methodol. 2015;15:35.
- The World's Richest and Poorest Countries 2021. [cited 2021 July 20]. Available from: https://www.gfmag.com/global-data/economic-data/worlds-richest-and-poorest-countries.
- Schellekens P, Sourrouille D. 2020. COVID-19 mortality in rich and poor countries: a tale of two pandemics? Policy research working paper; No. 9260. World Bank, Washington, DC. [cited 2021 July 20]. Available from: https://openknowledge.worldbank.org/handle/10986/33844.
- Cochrane Handbook. Part 2: General methods for Cochrane reviews > 9 Analysing data and undertaking meta-analyses > 9.7 Sensitivity analyses. [cited 2021 July 20]. Available from: https://handbook-5-1.cochrane.org/chapter_9/9_7_sensitivity_analyses.htm.
- Adhikari EH, Moreno W, Zofkie AC, et al. Pregnancy outcomes among women with and without severe acute respiratory syndrome coronavirus 2 infection. JAMA Netw Open. 2020;3(11):e2029256.
- Ahlberg M, Neovius M, Saltvedt S, et al. Association of SARS-CoV-2 test status and pregnancy outcomes. JAMA. 2020;324(17):1782–1785.
- Bender WR, Hirshberg A, Coutifaris P, et al. Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 philadelphia hospitals: carrier prevalence and symptom development over 2 weeks. Am J Obstet Gynecol Mfm. 2020;2(4):100226.
- Cardona-Pérez JA, Villegas-Mota I, Helguera-Repetto AC, et al. Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: results from universal screening in a tertiary care center in Mexico city, Mexico. PLOS One. 2021;16(4):e0249584.
- Chornock R, Iqbal SA, Wang T, et al. Incidence of hypertensive disorders of pregnancy in women with COVID-19. Am J Perinatol. 2021;38(8):766–762.
- Cruz Melguizo S, de la Cruz Conty ML, Carmona Payán P, et al. Pregnancy outcomes and SARS-CoV-2 infection: the Spanish obstetric emergency group study. Viruses. 2021;13(5):853.
- Díaz-Corvillón P, Mönckeberg M, Barros A, et al. Routine screening for SARS CoV-2 in unselected pregnant women at delivery. PLOS One. 2020;15(9):e0239887.
- Flaherman VJ, Afshar Y, Boscardin J, et al. Infant outcomes following maternal infection with SARS-CoV-2: First report from the PRIORITY study. Clin Infect Dis. 2021;73(9):e2810–e2813.
- Gupta P, Kumar S, Sharma SS. SARS-CoV-2 prevalence and maternal-perinatal outcomes among pregnant women admitted for delivery: experience from COVID-19-dedicated maternity hospital in Jammu, Jammu And Kashmir (India). J Med Virol. 2021;93(9):5505–5514.
- Hcini N, Maamri F, Picone O, et al. Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: a single-center prospective comparative study. Eur J Obstet Gynecol Reprod Biol. 2021;257:11–18.
- Patberg ET, Adams T, Rekawek P, et al. Coronavirus disease 2019 infection and placental histopathology in women delivering at term. Am J Obstet Gynecol. 2021;224(4):382.e1–382.e18.
- Pineles BL, Alamo IC, Farooq N, et al. Racial-ethnic disparities and pregnancy outcomes in SARS-CoV-2 infection in a universally-tested cohort in Houston, Texas. Eur J Obstet Gynecol Reprod Biol. 2020;254:329–330.
- Prabhu M, Cagino K, Matthews KC, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York city: a prospective cohort study. BJOG: Int J Obstet Gy. 2020;127(12):1548–1556.
- Rosenbloom JI, Raghuraman N, Carter EB, et al. Coronavirus disease 2019 infection and hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2021;224(6):623–624.
- Savirón-Cornudella R, Villalba A, Esteban LM, et al. Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing. Life Sci. 2021;271:119200.
- Trahan MJ, Malhamé I, O'Farrell P, et al. Obstetrical and newborn outcomes among patients with SARS-CoV-2 during pregnancy. J Obstet Gynaecol Can. 2021;43(7):888–892.e1.
- Yadav V, Goel N, Afreen N, et al. COVID 19 in pregnancy; obstetrical and neonatal outcomes: a retrospective comparative study. IJOGR. 2020;7(4):584–589.
- Shi L, Lin L. The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses. Medicine. 2019;98(23):e15987.
- Cordero CP, Dans AL. Key concepts in clinical epidemiology: detecting and dealing with heterogeneity in meta-analyses. J Clin Epidemiol. 2021;130:149–151.
- Reichelt AJ, Hirakata VN, Genro VK, et al. A snapshot of the prevalence of endocrine disorders in pregnancies complicated by coronavirus disease 2019: a narrative review with meta-analysis. Int J Gynaecol Obstet. 2021;154(2):204–211.
- Hua J, Shen J, Zhang J, et al. The association between COVID-19 pandemic and maternal isolated hypothyroxinemia in first and second trimesters. Psychoneuroendocrinology. 2021;128:105210.
- Pierce-Williams RAM, Burd J, Felder L, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. Am J Obstet Gynecol MFM. 2020;2(3):100134.
- Aabakke A, Krebs L, Petersen TG, et al. SARS-CoV-2 infection in pregnancy in Denmark – characteristics and outcomes after confirmed infection in pregnancy: a nationwide, prospective, population-based cohort study. Acta Obstet Gynecol Scand. 2021;100(11):2097–2110.
- Molenaar NM, Rommel AS, de Witte L, et al. Seroprevalence of SARS-CoV-2 during pregnancy and associated outcomes: results from an ongoing prospective cohort study. Paediatr Perinat Epidemiol. 2021. In press.
- Flannery DD, Gouma S, Dhudasia MB, et al. Transplacental Transfer of SARS-CoV-2 Antibodies. JAMA Pediatr. 2021;175(6):594–600.
- Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320.
- Chappell LC, Cluver CA, Kingdom J, et al. Pre-eclampsia. Lancet. 2021;398(10297):341–354.
- Stepan H, Hund M, Andraczek T. Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome. Hypertension. 2020;75(4):918–926.
- Lassi ZS, Ana A, Das JK, et al. A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity. J Glob Health. 2021;11:05018.
- Yang J, D’Souza R, Kharrat A, et al. COVID-19 pandemic and population-level pregnancy and neonatal outcomes: a living systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2021;100(10):1756–1770.
- Bouachba A, Allias F, Nadaud B, et al. Placental lesions and SARS-Cov-2 infection: diffuse placenta damage associated to poor fetal outcome. Placenta. 2021;112:97–104.
- Chmielewska B, Barratt I, Townsend R, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021;9(6):e759–e772.
- Garrido-Pontnou M, Navarro A, Camacho J, et al. Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise. Mod Pathol. 2021; 34(9):1704–1709.
- Hecht JL, Quade B, Deshpande V, et al. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Mod Pathol. 2020;33(11):2092–2103.
- Huntley BJF, Mulder IA, Di Mascio D, et al. Adverse pregnancy outcomes among individuals with and without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systematic review and meta-analysis. Obstet Gynecol. 2021;137(4):585–596.
- Gajbhiye RK, Sawant MS, Kuppusamy P, et al. Differential impact of COVID-19 in pregnant women from high-income countries and low- to middle-income countries: a systematic review and meta-analysis. Int J Gynaecol Obstet. 2021;155(1):48–56.
- Edlow AG, Li JZ, Collier AY, et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open. 2020;3(12):e2030455.
- Hessami K, Homayoon N, Hashemi A, et al. COVID-19 and maternal, fetal and neonatal mortality: a systematic review. J Matern Fetal Neonatal Med. 2020:1–6. In press.
- Yasa B, Memur S, Ozturk DY, et al. Severity of maternal SARS-CoV-2 infection in pregnancy predicts neonatal outcomes. Am J Perinatol. 2021. In press. DOI: 10.1055/s-0041-1733783